Obsidian Therapeutics Inc. (OBX:NASDAQ) closed at $13.98 on October 23, 2026, up 0.29% on the day. The stock trades 72.0% below its 52-week high of $49.97 and 21.4% above its 52-week low of $11.52. Over the past year, it lost 10.2%. Obsidian Therapeutics Inc. is part of the Health Care sector.
In 63 trading sessions since July 28, 2026, OBX closed higher on 27 days (43%). Its best day was August 4, 2026 (+79.04%) and its worst was August 13, 2026 (-32.43%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 1 time.
Obsidian Therapeutics, Inc. is a clinical-stage biopharmaceutical company harnessing novel protein-regulation technology to develop engineered TIL cell therapies for the treatment of patients with solid tumors. Obsidian's proprietary cytoDRiVE technology is designed to precisely regulate the timing and level of protein function by using FDA-approved small-molecule drugs.
Find more stocks like OBX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.